Companion animals such as dogs, cats, etc. have been around in and around human life for ages and to keep the animal healthy is a topmost priority of the caregivers. This is a very important factor in the growth of global companion animal drugs market. On the basis of several studies it is proven that human and companion animals have shown positive health results on both of them. Therefore it is of utmost important that companion animal’s needs veterinary healthcare as they are primary source of zoonotic diseases which can affect humans too. This need will increase the market growth of the global companion animal drugs.

Market summary
The global companion animal drugs market is growing due to increasing pet ownership which is leading to pet related expenditures as companion animals which are part of several families across developed and developed countries. With increasing health expenditure on pets, their health and their caregivers is bolstering the market growth of global companion animal drugs market.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-drugs-market/

Regional analysis
The U.S. dominates the North American companion animal drugs market holding the largest revenue share. Followed by Europe which holds a significant share over the forecasted period.


Notable market development
Merck animal Health (MSD animal Health) outside of USA and Canada received USFDA in 2016, approval for BRAVECTO (fluralaner topical solution), a topical treatment for treating ticks and fleas for dogs and cats
Avail sample report at https://bit.ly/2TrQu9T

Some of the key players in the global Companion Animal Drugs Market include
• Bayer AG (Germany)
• Boehringer Ingelheim GmbH (Germany)
• Ceva Santé Animale (France)
• Eli Lilly and Company (U.S)
• Hester biosciences (India)
• Merck & Co., Inc. (U.S)
• Vétoquinol S.A. (France)
• Virbac S.A. (France)
• Zoetis Inc. (U.S)

The global companion animal drugs market is divided into following categories-

By product type
• Antimicrobials
• Ectoparasiticides
• Endoparacitides
• Endectoparaciticides
• Anti-inflammatory Drugs
• Anti-Obesity Drugs
• Behavioral Products
• Biologic Drugs

By Animal Type
• Feline
• Canine
• Equine

By Route of Administration
• Oral
• Parenteral
• Topical

By Distribution Channel
• Veterinary Pharmacies
• Veterinary Hospitals
• Veterinary Clinics
• E-Commerce

By Geography
• North America
• Latin America
• Asia Pacific
• The Middle East and Africa
• Europe

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com